Corteva, Inc. (NYSE:CTVA) Position Boosted by Bridgewater Associates LP

Bridgewater Associates LP boosted its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 121.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 288,630 shares of the company's stock after acquiring an additional 158,439 shares during the period. Bridgewater Associates LP's holdings in Corteva were worth $16,440,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CTVA. M&T Bank Corp raised its stake in Corteva by 0.8% during the 3rd quarter. M&T Bank Corp now owns 2,077,000 shares of the company's stock worth $122,107,000 after acquiring an additional 16,087 shares in the last quarter. World Investment Advisors LLC purchased a new position in shares of Corteva during the third quarter worth about $319,000. Wilmington Savings Fund Society FSB increased its position in shares of Corteva by 247.9% during the third quarter. Wilmington Savings Fund Society FSB now owns 44,080 shares of the company's stock worth $2,591,000 after purchasing an additional 31,411 shares in the last quarter. Franklin Resources Inc. boosted its position in shares of Corteva by 6.1% in the 3rd quarter. Franklin Resources Inc. now owns 14,788,607 shares of the company's stock valued at $860,746,000 after purchasing an additional 856,007 shares during the period. Finally, 1ST Source Bank grew its stake in Corteva by 1.9% during the 3rd quarter. 1ST Source Bank now owns 19,195 shares of the company's stock worth $1,128,000 after buying an additional 367 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 26,560 shares of the stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the transaction, the insider now directly owns 11,347 shares in the company, valued at $723,257.78. This trade represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.14% of the stock is owned by company insiders.

Corteva Stock Performance

Shares of NYSE:CTVA traded down $0.70 on Monday, reaching $59.04. 278,583 shares of the company's stock were exchanged, compared to its average volume of 3,307,865. The business's 50-day moving average is $60.97 and its two-hundred day moving average is $60.31. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $66.24. The firm has a market capitalization of $40.33 billion, a price-to-earnings ratio of 45.77, a PEG ratio of 1.68 and a beta of 0.73.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, equities research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.15%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva's dividend payout ratio (DPR) is 52.71%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CTVA. Citigroup raised their price target on Corteva from $69.00 to $74.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Oppenheimer increased their price target on Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. UBS Group cut their price objective on shares of Corteva from $74.00 to $73.00 and set a "buy" rating for the company in a research report on Friday, January 10th. The Goldman Sachs Group initiated coverage on shares of Corteva in a report on Thursday, March 13th. They set a "buy" rating and a $71.00 price target for the company. Finally, BNP Paribas raised Corteva to a "hold" rating in a research note on Monday, February 10th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $68.13.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.